Ilario Giovanni Rapposelli

机构：Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Istituti di Ricovero e Cura a Carattere Scientifico · ORCID：0000-0003-1802-5671

发表论文 111 篇 · 总被引 920 次 · h-index 18

代表论文

• Preoperative mFOLFIRINOX versus PAXG for stage I–III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial (2025 · The Lancet · 被引 22)
• D-lactate and glycerol as potential biomarkers of sorafenib activity in hepatocellular carcinoma (2025 · Signal Transduction and Targeted Therapy · 被引 16)
• Durvalumab in Advanced Biliary Tract Cancer: Real‐World Data From a Large Cohort of Patients Across Multiple International Centers (2025 · Liver International · 被引 10)
• A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC ‐D Index (2025 · Liver International · 被引 9)
• Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real‐life worldwide population (2025 · International Journal of Cancer · 被引 4)
• The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: a large, real-life, worldwide population (2025 · JNCI Journal of the National Cancer Institute · 被引 4)